These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 19187586)

  • 21. Angiographic and intravascular ultrasound study of the effects of overlapping sirolimus- and paclitaxel-eluting stents: comparison with same drug-eluting overlapping stents.
    Kang WC; Oh KJ; Han SH; Ahn TH; Chung WJ; Shin MS; Koh KK; Choi IS; Shin EK
    Int J Cardiol; 2007 Dec; 123(1):12-7. PubMed ID: 17289176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Late outcomes after drug-eluting stent implantation in "real-world" clinical practice.
    Ramsdale DR; Rao A; Asghar O; Ramsdale KA; McKay E
    J Invasive Cardiol; 2008 Oct; 20(10):493-500. PubMed ID: 18829991
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation by optical coherence tomography of neointimal coverage of sirolimus-eluting stent three months after implantation.
    Takano M; Inami S; Jang IK; Yamamoto M; Murakami D; Seimiya K; Ohba T; Mizuno K
    Am J Cardiol; 2007 Apr; 99(8):1033-8. PubMed ID: 17437723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings.
    Kotani J; Awata M; Nanto S; Uematsu M; Oshima F; Minamiguchi H; Mintz GS; Nagata S
    J Am Coll Cardiol; 2006 May; 47(10):2108-11. PubMed ID: 16697331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of stem cell therapy with G-CSF on coronary artery after drug-eluting stent implantation in patients with acute myocardial infarction.
    Kang HJ; Kim YS; Koo BK; Park KW; Lee HY; Sohn DW; Oh BH; Park YB; Kim HS
    Heart; 2008 May; 94(5):604-9. PubMed ID: 18070947
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice. 4-year results from a large 2-institutional cohort study.
    Wenaweser P; Daemen J; Zwahlen M; van Domburg R; Jüni P; Vaina S; Hellige G; Tsuchida K; Morger C; Boersma E; Kukreja N; Meier B; Serruys PW; Windecker S
    J Am Coll Cardiol; 2008 Sep; 52(14):1134-40. PubMed ID: 18804739
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The incidence and clinical impact of stent strut fractures developed after drug-eluting stent implantation.
    Chung WS; Park CS; Seung KB; Kim PJ; Lee JM; Koo BK; Jang YS; Yang JY; Yoon JH; Kim DI; Yoon YW; Park JS; Cho YH; Park SJ
    Int J Cardiol; 2008 Apr; 125(3):325-31. PubMed ID: 17434616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence and predictors of drug-eluting stent fractures in long coronary disease.
    Kim HS; Kim YH; Lee SW; Park DW; Lee CW; Hong MK; Park SW; Ko JK; Park JH; Lee JH; Choi SW; Seong IW; Cho YH; Lee NH; Kim JH; Chun KJ; Park SJ;
    Int J Cardiol; 2009 Apr; 133(3):354-8. PubMed ID: 18508140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study.
    Alfonso F; Pérez-Vizcayno MJ; Hernández R; Bethencourt A; Martí V; López-Mínguez JR; Angel J; Iñiguez A; Morís C; Cequier A; Sabaté M; Escaned J; Jiménez-Quevedo P; Bañuelos C; Suárez A; Macaya C;
    J Am Coll Cardiol; 2008 Nov; 52(20):1621-7. PubMed ID: 18992651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Late stent thrombosis associated with coronary aneurysm formation after sirolimus-eluting stent implantation.
    Aziz S; Morris JL; Perry RA
    J Invasive Cardiol; 2007 Apr; 19(4):E96-8. PubMed ID: 17404416
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical features of late stent thrombosis after successful sirolimus-eluting stent implantation].
    He JQ; Chen F; Zhang XL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Nov; 35(11):1010-4. PubMed ID: 18269821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Moderate-severe renal insufficiency is a risk factor for sirolimus-eluting stent thrombosis. The RIFT study.
    Zhu ZB; Zhang RY; Zhang Q; Zhang JS; Hu J; Yang ZK; Shen WF
    Cardiology; 2009; 112(3):191-9. PubMed ID: 18682662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adverse clinical events in patients treated with sirolimus-eluting stents: the impact of Type D personality.
    Pedersen SS; Denollet J; Ong AT; Sonnenschein K; Erdman RA; Serruys PW; van Domburg RT
    Eur J Cardiovasc Prev Rehabil; 2007 Feb; 14(1):135-40. PubMed ID: 17301639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between neointimal coverage of sirolimus-eluting stents and lesion characteristics: a study with serial coronary angioscopy.
    Yamamoto M; Okamatsu K; Inami S; Takano M; Yokoyama S; Ohba T; Ibuki C; Hata N; Seino Y; Mizuno K
    Am Heart J; 2009 Jul; 158(1):99-104. PubMed ID: 19540398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term efficacy and safety of Chinese made sirolimus eluting stents: results, including off label usage, from two centres over three years.
    Zhang Q; Xu B; Yang YJ; Qiao SB; Zhang RY; Zhang JS; Hu J; Qin XW; Chen JL; Shen WF; Gao RL
    Chin Med J (Engl); 2008 Sep; 121(17):1670-4. PubMed ID: 19024097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The fate of patients with clinical recurrence after sirolimus-eluting stent implantation (a two-year follow-up analysis from the SIRIUS trial).
    Moussa ID; Moses JW; Kuntz RE; Holmes DR; Popma JJ; Teirstein PS; Wong SC; Leon MB
    Am J Cardiol; 2006 Jun; 97(11):1582-4. PubMed ID: 16728218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The fate of incomplete stent apposition with drug-eluting stents: an optical coherence tomography-based natural history study.
    Ozaki Y; Okumura M; Ismail TF; Naruse H; Hattori K; Kan S; Ishikawa M; Kawai T; Takagi Y; Ishii J; Prati F; Serruys PW
    Eur Heart J; 2010 Jun; 31(12):1470-6. PubMed ID: 20363765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of multiple overlapping sirolimus-eluting stents for treatment of long coronary artery lesions: results from a single-center registry in 318 consecutive patients.
    Ruchin PE; Trabattoni D; Fabbiocchi F; Montorsi P; Lualdi A; Ravagnani P; Grancini L; Galli S; Teruzzi G; Calligaris G; De Martini S; Bartorelli AL
    Int J Cardiol; 2009 May; 134(2):231-7. PubMed ID: 18582971
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 2-year clinical outcomes after implantation of sirolimus-eluting, paclitaxel-eluting, and bare-metal coronary stents: results from the WDHR (Western Denmark Heart Registry).
    Kaltoft A; Jensen LO; Maeng M; Tilsted HH; Thayssen P; Bøttcher M; Lassen JF; Krusell LR; Rasmussen K; Hansen KN; Pedersen L; Johnsen SP; Sørensen HT; Thuesen L
    J Am Coll Cardiol; 2009 Feb; 53(8):658-64. PubMed ID: 19232897
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Late incomplete stent apposition after sirolimus-eluting stent implantation: a serial intravascular ultrasound analysis.
    Ako J; Morino Y; Honda Y; Hassan A; Sonoda S; Yock PG; Leon MB; Moses JW; Bonneau HN; Fitzgerald PJ
    J Am Coll Cardiol; 2005 Sep; 46(6):1002-5. PubMed ID: 16168282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.